News

I am a 71-year-old male with Type 2 diabetes. My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my ...
I am a 71-year-old male with Type 2 diabetes. My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my weight by about 20 pounds and my A1C level by about 0.5%. I ...
As President Donald Trump nears three months in office for his second term, his approval rating is being closely watched as his administration continues to pursue aggressive policies on ...
The once-daily treatment lowered A1C - a measurement of blood sugar ... BofA reiterated its buy rating on Lilly's stock and its $1,000 stock target, which implies 20% upside from the current ...
In the first Phase 3 trial of the ACHIEVE program, orforglipron met the primary endpoint of superior A1C reduction compared to placebo at 40 weeks, lowering A1C by an average of 1.3% to 1.6% from ...
Trump had a 57% approval, 39% disapproval rating in Utah surveys through April 16, close to where he has been for weeks. Drew Linzer, the director of Civiqs, previously told the USA TODAY Network ...
Teams need – read: crave – solid TV ratings to feed current and prospective sponsors. Said one team owner to me in a message Tuesday afternoon, shortly after news of Long Beach’s average ...
Netflix’s word-of-mouth breakout Adolescence climbed to the top of the U.S. streaming charts in late March ... Nielsen’s streaming ratings cover viewing on TV sets only and don’t include ...
By Rick Porter Television Business Editor Netflix’s word-of-mouth breakout Adolescence climbed to the top of the U.S. streaming charts in late ... Nielsen’s streaming ratings cover viewing ...
Orforglipron cut A1C by 1.2–1.5% and reduced weight up to 15.8 lbs in adults with type 2 diabetes. Over 65% of high-dose patients reached an A1C of 6.5% or less after 40 weeks of treatment.
Orforglipron, a first-of-its-kind oral small molecule GLP-1 receptor agonist, demonstrated significant reductions in A1C levels and weight ... With a strong financial health rating on InvestingPro ...